Skip to main content
. 2011 Oct;179(4):2120–2130. doi: 10.1016/j.ajpath.2011.07.002

Table 1.

Clinical and Immunohistochemical Characteristics of 44 Human Pituitary Adenomas

Clinical diagnosis Immunohistochemical status
FSH LH TSH α-Subunit PRL GH ACTH
Nonfunctioning adenoma
 1 rare rare rare 1+
 2
 3 rare rare
 4 3+ 1+ rare
 5 3+ 4+ 3+ 1+
 6 1+ rare rare
 7 rare rare
 8 rare
 9 rare
 10 rare rare
 11 3+ 4+ 4+ rare rare
 12 2+ 3+ 1+ 1+ rare
 13 1+ 1+ 1+ rare rare rare
 14 rare 2+ 1+ rare
 15 1+ rare rare
 16 1+ 1+ 1+ rare
 17 1+ rare 1+ 1+
 18 4+ 4+ rare rare
 19 rare rare rare rare rare
 20 1+ 1+ 1+ 1+ rare
 21 3+ 3+ 1+ rare 1+
 22 1+ 1+ 1+ 1+ 1+
 23 rare 1+
 24
 25
Acromegaly
 26 ND ND ND rare 3+ ND
 27 rare 1+ 2+ 3+ 1+
 28 3+ 4+
 29 rare rare 3+ 3+ rare 4+
 30 ND ND ND 2+ 2+ 4+ ND
 31 ND ND ND ND 4+ ND
 32 ND ND ND ND 2+ 3+ ND
Prolactinoma
 33 4+ 2+
 34 4+ 2+
 35 4+
 36 4+
 37 4+
Cushing's disease
 38 rare 4+
 39 ND ND ND ND ND 4+
 40 ND ND ND ND 4+
 41 4+
 42 ND ND ND ND rare ND 4+
 43 1+ rare 4+
 44 1+ 4+

ACTH, adrenocorticotropic hormone; FSH, follicle-stimulating hormone; GH, somatotropin (growth hormone); LH, luteinizing hormone; PRL, prolactin; TSH, thyrotropin (thyroid-stimulating hormone); α-subunit of glycoprotein hormones.

Immunostaining was graded by the number of positive cells: −, negative; rare, only a few cells are positive; 1+, 1% to 5% positivity; 2+, 6% to 20% positivity; 3+, 21% to 50% positivity; 4+, >50% positivity; ND, not done (staining was not performed).